FAQ

A standard course runs 15 to 20 weeks, though some patients need up to six months to reach the cumulative dose target of 120–150 mg per kilogram of body weight. Low-dose protocols take longer. Skin often continues improving for one to two months after the last capsule.

Most patients start at 0.5 mg per kilogram of body weight daily, increasing to about 1 mg/kg after the first month if tolerated. A 70 kg person typically takes 30–40 mg initially, then 60–80 mg. Your dermatologist adjusts based on response and side effects.

Isotretinoin is typically reserved for severe nodular or cystic acne, acne that failed at least two other treatments, or acne causing scarring or significant distress. A dermatologist weighs your treatment history, health background, and ability to meet monitoring requirements before prescribing.

Yes. About 20–40% of patients relapse enough to consider retreatment, and second courses are safe and effective after a break of at least two months. Relapsed acne is usually milder, and some patients only need topical maintenance instead of a full second course.

Dry lips affect over 90% of patients — it is nearly universal. Dry skin, dry eyes, nosebleeds, sun sensitivity, and mild joint aches follow close behind. These are managed with lip balm, moisturizer, artificial tears, saline spray, and daily sunscreen rather than stopping treatment.

Large studies have not confirmed a causal link, and many patients report improved mood as severe acne clears. Individual reports exist, so mood is monitored throughout treatment. Report any new depression, anxiety, or thoughts of self-harm to your prescribing doctor immediately.

Possibly — the purge affects a significant minority of patients during weeks two through six. Accelerated skin turnover pushes existing clogged pores to the surface all at once. It is temporary, it means the medication is working, and improvement typically follows within weeks.

Almost never. Dryness, aches, hair thinning, and lab changes reverse within weeks to months after the course ends. The exception is birth defects from pregnancy exposure, which is why prevention is absolute. Rare reports of persistent symptoms remain an area of ongoing research.

Baseline and monthly panels covering triglycerides, cholesterol, and liver enzymes (ALT and AST). Patients who can become pregnant also complete monthly pregnancy tests through iPLEDGE. Abnormal results usually mean dose adjustment or dietary changes rather than stopping treatment entirely.

Minimal to none is the safe answer. Both alcohol and isotretinoin are processed by the liver, and combining them raises the chance of enzyme elevations that could interrupt your course. An occasional single drink is unlikely to cause harm, but regular drinking works against you.

Usually yes, but expect drier eyes than usual. Preservative-free artificial tears help most wearers stay comfortable. Some patients switch to glasses on particularly dry days or for the final months of the course. Persistent irritation deserves a check-in with an eye doctor.

Keep it minimal and gentle: a non-foaming cleanser, a rich fragrance-free moisturizer twice daily, thick lip balm reapplied constantly, and SPF 30+ every morning. Stop exfoliants, retinol products, and harsh acne treatments — isotretinoin is doing that work internally, and skin is fragile.

Isotretinoin causes severe birth defects — affecting the brain, heart, and face — in a high percentage of exposed pregnancies. There is no safe dose during pregnancy. This is the most serious risk of the medication and the reason the iPLEDGE program exists.

iPLEDGE is the FDA-mandated risk management program that every US isotretinoin patient must join. It requires monthly doctor visits, monthly attestations, and — for patients who can become pregnant — two forms of contraception plus monthly pregnancy tests before each prescription is dispensed.

One month. Isotretinoin clears from the body within weeks, and iPLEDGE requires continued contraception for exactly one month after the final dose. After that window, the medication has no known effect on future fertility or future pregnancies.

Not directly — isotretinoin has no effect on hormones or muscle protein synthesis, and it is not a steroid. Indirectly, joint pain and fatigue at higher doses can limit heavy training, which is why lifters gravitate toward low-dose protocols of 10–20 mg daily.

It is done in the community, but it stacks risks: both isotretinoin and oral steroids stress the liver, and both worsen cholesterol. The consistent advice is to avoid oral steroids entirely during treatment, keep doses low, and run monthly liver and lipid panels.

Baseline bloodwork before starting, monthly liver and lipid panels, no oral steroids, no tetracycline antibiotics, aggressive hydration, moisturizer and sunscreen, minimal alcohol, and honest medical supervision. Isotretinoin solves steroid acne effectively, but unmonitored self-treatment is where serious problems begin.